Company performance
Add to research
Current Price
as of Jun 18, 2025$0.38
P/E Ratio
N/A
Market Cap
$22.8M
Description
Add to research
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.
Metrics
Add to research
Overview
- HQBoston, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerELEV
- Price$0.3849+0.86%
Trading Information
- Market cap$22.80M
- Float89.50%
- Average Daily Volume (1m)2,025,287
- Average Daily Volume (3m)1,462,151
- EPS-$0.81
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$14.21M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$10.84M
- EV-$34.07M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.49
- Debt/Equity66.87
Documents
Add to research
SEC Filings